Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG

Journal of Cardiothoracic Surgery

Volumn 4, Issue , 2009, Pages

  Eifert, Sandra ^a   Rasch, Astrid ^a   Beiras Fernandez, Andres ^a   Nollert, Georg ^a   Reichart, Bruno ^a   Lohse, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEPATIC LIPASE, HUMAN; TRIACYLGLYCEROL LIPASE;

ARTICLE; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; REOPERATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TREATMENT OUTCOME;

APOLIPOPROTEINS E; COHORT STUDIES; CORONARY ARTERY BYPASS; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPASE; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REOPERATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 70049097918     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-4-46     Document Type: Article

References (20)

1. Nabel EG Cardiovascular Disease N Engl J Med 2003, 349:60-72 10.1056/ NEJMra035098 12840094
2. Rossi GP Maiolino G Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors J Am Coll Cardiol 2004, 44(1):209f 10.1016/ j.jacc.2004.04.005
3. Curtiss LK Boisvert WA Apolipoprotein E and atherosclerosis Curr Opin Lipidol 2000, 11:243-251 10.1097/00041433-200006000-00004 10882339
4. Baroni MG Berni A Romeo S Arca M Tesorio T Sorropago G Di Mario U Galton DJ Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): Variation in LIPC gene associates with clinical outcomes in patients with established CAD BMC Med Genet 2003, 4:8-16 10.1186/1471-2350-4-8 201027 12964943
5. Wang XL Sim AS Badenhop RF McCredie RM Wilcken DE A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene Nat Med 1996, 1:41-5 10.1038/ nm0196-41 8564837
6. Buchholz T Lohse P Kosian E Thaler CJ Vasoconstrictively acting AT1R A1166C and NOS3 4/5 polymorphisms in recurrent spontaneous abortions (RSA) Am J Reprod Immunol 2004, 51(5):323-8 10.1111/ j.1600-0897.2004.00163.x 15212666
7. de Andrade FM Silveira FR Arsand M Antunes AL Torres MR Zago AJ Callegari-Jaques SM Hutz MH Association between -250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population Clin Genet 2004, 65(5):390-5 10.1111/j.0009-9163.2004.00243.x 15099346
8. Grunenfelder J Umbehr M Plass A Bestmann L Maly FE Zünd G Turina M Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass J Thorac Cardiovasc Surg 2004, 128(1):92-7 10.1016/j.jtcvs.2004.02.022 15224026
9. Chaaba R Smaoui M Hammami S Attia N Ben Hamda K Masmoudi AS Mahjoub S Bouslama A Ben Farhat M Girard-Globa A Hammami M Role of cholesteryl ester transfer protein activity and genetic polymorphism in ischemic heart diasease in type II diabetic patients Tunis Med 2004, 82(3):282-8 15382463
10. Anvari A Schuster E Gottsauner-Wolf M Wojta J Huber K PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease Thromb Res 2001, 103(2):103-7 10.1016/S0049-3848(01)00277-8 11457467
11. Zahn R Beeck H Winkelmann BR Seidl K Schneider S Hellstern P Senges J Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease Blood Coagul Fibrinolysis 2002, 13(2):81-7 10.1097/00001721-200203000-00002 11914649
12. Russo C Girelli D Olivieri O Guarini P Manzato F Pizzolo F Zaia B Mazzucco A Corrocher R G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease Circulation 2001, 103(20):2436-40 11369682
13. Mackensen GB Swaminathan M Ti LK Grocott HP Phillips-Bute BG Mathew JP Newman MF Milano CA Stafford-Smith M Perioperative Outcomes Research Group; Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.) Investigators of the Duke Heart Center. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG Ann Thorac Surg 2004, 78(2):520-6 10.1016/j.athoracsur.2004.02.106 15276511
14. Gaynor JW Gerdes M Zackai EH Bernbaum J Wernovsky G Clancy RR Newman MF Saunders AM Heagerty PJ D'Agostino JA et al Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery J Thorac Cardiovasc Surg 2003, 126(6):1736-45 10.1016/S0022-5223(03)01188-7 14688681
15. Silbert BS Evered LA Scott DA Cowie TF The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery Ann Thorac Surg 2008, 86(3):841-7 10.1016/j.athoracsur.2008.04.085 18721571
16. Kuukasjärvi P Tarkka M Mennander A Ilveskoski E Koivisto AM Laippala P Mikkelsson J Karhunen PJ Apolipoprotein E polymorphism is not a predictor for repeated coronary artery bypass surgery Scand Cardiovasc J 2005, 39(4):220-4 10.1080/14017430510009159 16118069
17. Wang XL Cigarette smoking, DNA variants in endothelial nitric oxide synthase gene and vascular disease Contribution Nephrology 2000, 130:53-67 full_text
18. Murtomaki S Tahvanainen E Antikainen M Tiret L Nicaud V Jansen H Ehnholm C Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from finnish EARS participants Arterioscler Thromb Vasc Biol 1997, 17(10):1879-1884 9351349
19. Taylor KD Scheuner MT Yang H Wang Y Haritunians T Fischel-Ghodsian N Shah PK Forrester JS Knatterud G Rotter JI Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts Genet Med 2004, 6(6):481-6 15545743
20. Knatterud GL Rosenberg Y Campeau L Geller NL Hunninghake DB Forman SA Forrester JS Gobel FL Herd JA Hickey A et al Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators Circulation 2000, 102(2):157-65 10889125